1 / 3

Neuromodulation Market Worth US$ 11 Billion Globally By 2022

The Global Neuromodulation Market is expected to exceed more than US$ 11 Billion by 2022 and will grow at a CAGR of more than 11% in the given forecast period.

Télécharger la présentation

Neuromodulation Market Worth US$ 11 Billion Globally By 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Neuromodulation Market Worth US$ 11 Billion Globally By2022 • Market Research Engine has published a new report titled as “Neuromodulation Market By Technology Analysis (Internal neuromodulation, External neuromodulation); By Application Analysis (Chronic Pain Management, Tremor, Failed back syndrome, Epilepsy, Depression, Urinary and Fecal Incontinence, Dystonia, Obsessive- Compulsive Disorder, Gastroparesis, Migraine, Parkinson’s disease); By Biomaterial Analysis (Polymeric Biomaterials, Metallic Biomaterials, Ceramic Biomaterials) and By Regional Analysis – Global Forecast by 2016 –2022”. • The Global Neuromodulation Market is expected to exceed more than US$ 11 Billion by 2022 and will grow at a CAGR of more than 11% in the given forecastperiod. • Browse Full ResearchReport: • https://www.marketresearchengine.com/reportdetails/neuromodulation-market-report • Neurological disorders which include epilepsy, alzheimer disorder, cerebrovascular sicknesses, and Parkinson’s disease have an effect on the critical and peripheral anxious machine. Bacterial, viral, and fungal infections also can reason neurological disorders. To manage such problems, neuromodulation is used; in which small electrodes generate electric most precise stimulation with the help of pulse generators to complement neurological activities in effected humans. The electrodes are normally located without delay within the mind or peripheral nerves or spinal twine while pulse mills are implanted within the pores andskin. • The major driving factors of Global Neuromodulation Market are asfollows: • Increase in geriatricpopulation • Rise in awareness regarding the efficacy and safety of neurostimulatordevices. • Growing incidence of neurological diseases • The restraining factors of Global Neuromodulation Market are asfollows: • Stringent approvalpolicies • Lack of trained healthcareprofessionals • The Global Neuromodulation Market is segmented on the lines of its technology, application and biomaterial. Technology segmentation is further classified into internal neuromodulation and external neuromodulation. Based on internal neuromodulation segmentation it covers deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nervestimulation. • Based on application segmentation it covers chronic pain management, tremor, failedback • syndrome, epilepsy, depression, urinary and fecal incontinence, dystonia, obsessive compulsive, disorder, gastroparesis, migraine, parkinson’s disease and other applications. Under biomaterial segmentation it covers polymeric biomaterials, metallic biomaterials and ceramic biomaterials. The Global Neuromodulation market on geographicsegmentation

  2. covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCCcountries. • Request A Sample Report: https://www.marketresearchengine.com/requestsample/neuromodulation-market-report • This reportprovides: • An overview of the global market for Global Neuromodulation and relatedtechnologies. • Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through2022. • Identifications of new market opportunities and targeted promotional plans for Global Neuromodulation Market. • Discussion of research and development, and the demand for new products and new applications. • Comprehensive company profiles of major players in theindustry. • REPORTSCOPE: • The scope of the report includes a detailed study of global and regional markets for Global Neuromodulation Market with the reasons given for variations in the growth of the industry in certain regions. • The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc, St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation and NeuroPace Inc. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments. • The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influentialplayers. • The Global Neuromodulation Markethas been segmented as below: By Technology Analysis • Internal neuromodulation o Deep BrainStimulation • Spinal CordStimulation • Vagus NerveStimulation • Sacral NerveStimulation • Other NeuromodulationTechnologies • Externalneuromodulation • Transcranial MagneticStimulation • Transcutaneous Electrical NerveStimulation • By ApplicationAnalysis

  3. Chronic PainManagement • Tremor • Failed backsyndrome • Epilepsy • Depression • Urinary and FecalIncontinence • Dystonia • Obsessive-CompulsiveDisorder • Gastroparesis • Migraine • Parkinson’sdisease • OtherApplications • By BiomaterialAnalysis • PolymericBiomaterials • MetallicBiomaterials • CeramicBiomaterials • By RegionalAnalysis • North America • Europe • Asia-Pacific • Rest of theWorld • Reasons to Buy thisReport: • Obtain the most up to date information available on all Global NeuromodulationMarket. • Identify growth segments and opportunities in theindustry. • Facilitate decision making on the basis of strong historic and forecast of Global Neuromodulation Marketdata. • Assess your competitor’s refining portfolio and itsevolution. • AboutMarketResearchEngine • Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop businessstrategies. • MediaContact • Contact Person: JohnBay • Email: john@marketresearchengine.com Phone: +1-855-984-1862 • Country: United States • Website:https://www.marketresearchengine.com

More Related